Three-Year prevalence and incidence of diabetes among American Indian youth in Montana and Wyoming, 1999 to 2001 - 29/08/11
, Janet M. McDowall, RN, BSN, Steven D. Helgerson, MD, MPH, Dorothy Gohdes, MD
Reprint requests: Todd S. Harwell, MPH, Montana Department of Public Health and Human Services, Cogswell Building, C-317, PO Box 202951, Helena, MT 59620-2951.Abstract |
Objectives |
To estimate the prevalence and incidence of type 2 diabetes among American Indian youth.
Study design |
Medical records were reviewed annually for all patients with diabetes who were <20 years of age at 6 Indian Health Service facilities in Montana and Wyoming. All cases ≤5 years of age or weight per age ≤10th percentile at diagnosis or with islet cell antibodies were considered as probable type 1. Among the remaining cases, probable type 2 diabetes was defined when a child had one or more of the following characterisitics: weight per age ≥95th percentile or acanthosis nigricans at diagnosis, elevated C-peptide or insulin, family history of type 2 diabetes; treatment with oral agents with or without insulin or no hypoglycemic therapy after 1 year of follow-up.
Results |
From 1999 to 2001, 53% of prevalent cases and 70% of incident cases were categorized as probable type 2 diabetes. The average annual prevalence of probable type 1 and type 2 diabetes was 0.7 and 1.3 per 1000. The average annual incidence rates for probable type 1, and type 2 diabetes were 5.8, 23.3 per 100,000.
Conclusions |
The incidence of probable type 2 diabetes was approximately 4 times higher than type 1 diabetes among American Indian youth in Montana and Wyoming
Le texte complet de cet article est disponible en PDF.Abbreviations : IHS
Plan
 | Supported by the Centers for Disease Control and Prevention, Division of Diabetes Translation, and through a cooperative agreement (U32/CCU815663-04) with the CDC, Division of Diabetes Translation. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the CDC or the IHS. |
Vol 143 - N° 3
P. 368-371 - septembre 2003 Retour au numéro
Article précédent
- Effect of corticosteroids in addition to intravenous gamma globulin therapy on serum cytokine levels in the acute phase of Kawasaki disease in children
- Yasunori Okada, Makoto Shinohara, Tomio Kobayashi, Yoshinari Inoue, Takeshi Tomomasa, Tohru Kobayashi, Akihiro Morikawa
- Decreased energy expenditure is caused by abnormal body composition in infants with Prader-Willi Syndrome
- M.Tracy Bekx, Aaron L Carrel, Timothy C Shriver, Zhanhai Li, David B Allen
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?